COVID-19 Pandemic Had Minimal Emotional Impact in Progressive MS Patients

Oct 02, 2020, 12:00 AM

Episode image
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses the pandemic’s minimal emotional impact on people with progressive MS. Plus, Multiple Sclerosis News Today’s columnist and forums moderator, Ed Tobias, considers the importance of a patient-doctor risk-benefit analysis before deciding on a treatment.
=====================================
Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
http://ChangesInRMS.com
=====================================
Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/